440 filings
Page 4 of 22
CORRESP
zp3qikv6tta24yve
21 Nov 22
Correspondence with SEC
12:00am
UPLOAD
lv1in vz1l45rskxn3h
21 Nov 22
Letter from SEC
12:00am
8-K
bz14 z5gjb0xdqr
14 Nov 22
AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
143zcekx8o0wlgudw
25 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:52pm
8-K
ym43jd6s298ypxfnd
23 Sep 22
Submission of Matters to a Vote of Security Holders
4:16pm
D
mkbp8u8mbnkv55559o8
17 Aug 22
$629.96K in equity / options / securities to be acquired, sold $629.96K, 1 investor
2:15pm
DEFA14A
3ggd0xp1xfndeils8qex
12 Aug 22
Additional proxy soliciting materials
4:57pm
8-K
ohe0h
12 Aug 22
Material Modifications to Rights of Security Holders
4:09pm
8-K
shmcnrh0dqw1
11 Aug 22
AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:08pm
8-K
itet73v7e2e8tr8
4 Aug 22
Entry into a Material Definitive Agreement
9:15am
8-K
09xtg1
28 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K/A
c2r7x
26 Jul 22
Submission of Matters to a Vote of Security Holders
5:19pm
8-K/A
4tvyfu9x cdxy1z7h7
25 Jul 22
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
4osktk
18 Jul 22
Additional proxy soliciting materials
4:05pm
8-K
82vsvq5ig i97hegbx56
15 Jul 22
Submission of Matters to a Vote of Security Holders
5:07pm